| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Darapladib |
|---|
| Description | Darapladib (SB-480848), is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor (IC50 of 0.25 nM). It produces sustained inhibition of plasma Lp-PLA2 activity in humans receiving intensive atorvastatin therapy. Lp-PLA2 inhibition with Darapladib also reduces the development of coronary atherosclerotic plaques. MW: 666.78. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[2-(diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]- |
|---|
| Gene, Accession, CAS # | CAS: 356057-34-6 |
|---|
| Catalog # | B1265-25 |
|---|
| Price | |
|---|
| Order / More Info | Darapladib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|